Cell and Gene Therapy Service Market Opportunity Assessment

Project Overview

A stealth DNA synthesis player wanted to understand how customers could use its cutting-edge technology and which applications to target for further development

DeciBio Approach

Primary Research

Conducted 24 interviews with biopharma and academic stakeholders with involvement in all stages from discovery to clinical phase to gather feedback on the client's target product profile and understand potential adoption, utilization, and willingness-to-pay

Secondary Research

Compared competitor capabilities, offerings, and revenues to triangulate the market size model

Quantitative Analysis

Built a bottom-up market model segmented by competitor and modality, with a 5-year growth projection
Assessed average willingness-to-pay by product type

‍

At a glance

Interviews

Modalities Modeled

Outcomes

The findings were delivered to the client C-suite and used to develop their strategy and marketing position as they transitions out of stealth mode.

Timeline

5 weeks

Geographic Scope

U.S.

Industry

Pharma & Biotech

capabilities

Voice-Of-Customer Research

Application Identification

Novel Technology Commercialization

Addressable Market Sizing

Cell and Gene Therapy Services Landscape Assessment

Cell and Gene Therapy Service Market Opportunity Assessment

Synthetic Oligonucleotides Market Sizing

Cell and Gene Therapy Service Market Opportunity Assessment

Cell and Gene Therapy Services Landscape Assessment

Cell Therapy Tools Provider Revenue Forecast and Market Positioning

Commercial Due Diligence in Digital Pathology

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

Discover how we can help